share_log

HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $55 Price Target

Benzinga ·  May 3 15:20

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $55 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment